Citigroup Inc. vs Nuwellis Inc — how do they compare? Citigroup Inc. trades at $137.9 (market cap $227.75B), while Nuwellis Inc trades at $1.4 (market cap $542.80K). The key difference: Citigroup Inc. is far larger — about 419583.6× Nuwellis Inc's market cap, and Citigroup Inc. pays a 1.97% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| C | NUWE | |
|---|---|---|
Market Cap | $227.75B | $542.80K |
Sector | Financials | Technology |
52-Week High | $145.67 | $220.50 |
52-Week Low | $92.59 | $1.42 |
Dividend Yield | 1.97% | — |
Enterprise Value | — | -$1.27M |
Signals from Pluang's Aura AI — not financial advice
Citigroup (C) trades at $135.22, up 0.17% with bullish technical signals and strong fundamental momentum. The stock shows robust earnings performance with Q1 and Q2 2026 beats, revenue growth to $85.21B in 2025, and improving profit margins. Analyst consensus is strongly bullish with a $154.38 price target, supported by recent strategic hires and digital transformation initiatives.
Outlook remains positive with revenue projected to reach $91.4B in 2026 and net income margin expanding to 19.52%. Key risks include volatile cash flow patterns and high debt levels. The current valuation at 14.63 P/E offers attractive upside potential relative to analyst targets, though investors should monitor execution of the bank's transformation strategy.
NUWE trades at $1.43, up 0.7% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of -$17.52M in 2025, with a negative net income margin of -217.22%, though recent news highlights product development and revenue growth initiatives, including a 14% preliminary year-over-year revenue increase in Q2 2026.
Outlook is cautious due to persistent losses and high cash burn, but growth in pediatric installations and strategic expansions offer potential. Risks include financial sustainability and competitive pressures, while analyst coverage is limited with a split buy/hold consensus.
Trailing returns across standard periods
Latest headlines on both assets
Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.
Read more on C →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →